These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37823928)

  • 21. Interventions for the management of transient tachypnoea of the newborn - an overview of systematic reviews.
    Bruschettini M; Hassan KO; Romantsik O; Banzi R; Calevo MG; Moresco L
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013563. PubMed ID: 35199848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.
    Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A
    Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Failure of non-invasive continuous positive airway pressure as the initial respiratory support in very preterm infants: a multicenter prospective cohort study].
    Multicenter Study Collaborative Group for Evaluation of Outcomes in Very Low Birth Weight Infants
    Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):273-279. PubMed ID: 33775045
    [No Abstract]   [Full Text] [Related]  

  • 24. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial.
    Escobedo MB; Gunkel JH; Kennedy KA; Shattuck KE; Sánchez PJ; Seidner S; Hensley G; Cochran CK; Moya F; Morris B; Denson S; Stribley R; Naqvi M; Lasky RE;
    J Pediatr; 2004 Jun; 144(6):804-8. PubMed ID: 15192630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative routes of surfactant application - An update.
    Kribs A; Roberts KD; Trevisanuto D; O' Donnell C; Dargaville PA
    Semin Fetal Neonatal Med; 2023 Dec; 28(6):101496. PubMed ID: 38040586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant Components and Tracheal Aspirate Inflammatory Markers in Preterm Infants with Respiratory Distress Syndrome.
    Verlato G; Simonato M; Giambelluca S; Fantinato M; Correani A; Cavicchiolo ME; Priante E; Carnielli V; Cogo P
    J Pediatr; 2018 Dec; 203():442-446. PubMed ID: 30270169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Respiratory failure in "late preterm" infants: a retrospective cohort study].
    Condò V; Colnaghi M; Vanzatiz M; Mercadante D; Pierro M; Vendettuoli V; Ronchi A; Mosca F
    Pediatr Med Chir; 2009; 31(6):241-5. PubMed ID: 20333882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
    Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can we balance early exogenous surfactant therapy and non-invasive respiratory support to optimise outcomes in extremely preterm infants? A nuanced review of the current literature.
    Glaser K; Bamat NA; Wright CJ
    Arch Dis Child Fetal Neonatal Ed; 2023 Nov; 108(6):554-560. PubMed ID: 36600473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of respiratory distress syndrome in infants of different gestational ages.
    Sun H; Xu F; Xiong H; Kang W; Bai Q; Zhang Y; Zhou C; Zhuang F; Wang X; Zhu C
    Lung; 2013 Aug; 191(4):425-33. PubMed ID: 23722460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol.
    Ines F; Hutson S; Coughlin K; Hopper A; Banerji A; Uy C; Finer N; Rich W; Morales A; Steen J; Katheria AC
    BMJ Open; 2021 Jan; 11(1):e038343. PubMed ID: 33483435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study of evaluation of semi-rigid and flexible catheters for less invasive surfactant administration in preterm infants with respiratory distress syndrome-a randomized controlled trial.
    Auer-Hackenberg L; Brandner J; Hofstätter E; Stroicz P; Hager T; Eichhorn A; Schütz S; Feldner R; Wald M
    BMC Pediatr; 2022 Nov; 22(1):637. PubMed ID: 36333741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Changes in Early Respiratory Support Management on Respiratory Outcomes of Preterm Infants.
    Xie L; Luo X; Li B; Du L; Wang Z; Liu Y; Chen J; Duan S; Yan L; Gao W
    Respir Care; 2022 Oct; 67(10):1310-1319. PubMed ID: 35764345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.
    Dargaville PA; Kamlin CO; De Paoli AG; Carlin JB; Orsini F; Soll RF; Davis PG
    BMC Pediatr; 2014 Aug; 14():213. PubMed ID: 25164872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial.
    Yang Y; Yan W; Ruan M; Zhang L; Su J; Deng H; Li M
    BMC Pediatr; 2022 Jan; 22(1):14. PubMed ID: 34980047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome.
    Federici C; Fornaro G; Roehr CC
    Eur J Hosp Pharm; 2022 Nov; 29(6):346-352. PubMed ID: 33658228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous positive airway pressure for spontaneously breathing premature infants with respiratory distress syndrome.
    Saxena A; Thapar RK; Sondhi V; Chandra P
    Indian J Pediatr; 2012 Sep; 79(9):1185-91. PubMed ID: 22396227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.